2-n-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine has been researched along with Diabetes Mellitus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brozinick, JT; Cushman, SW; Gibbs, EM; Hargrove, DM; McCoid, SC; Nardone, NA; Reynolds, TH; Stevenson, RW | 1 |
1 other study(ies) available for 2-n-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine and Diabetes Mellitus
| Article | Year |
|---|---|
GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cure.
Topics: Animals; Azides; Biological Transport; Cell Membrane; Deoxyglucose; Diabetes Mellitus; Disaccharides; Dose-Response Relationship, Drug; Glucose Clamp Technique; Glucose Tolerance Test; Glucose Transporter Type 4; Glycosides; Humans; Hypoglycemic Agents; Insulin; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monosaccharide Transport Proteins; Muscle Proteins; Propylamines | 2001 |